RECURRENT GLIOSARCOMA
Clinical trials for RECURRENT GLIOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOSARCOMA trials appear
Sign up with your email to follow new studies for RECURRENT GLIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tailored tumor attack: can custom drug cocktails beat recurrent glioblastoma?
Disease control CompletedThis pilot study tested whether it's possible to quickly create and start a personalized drug combination for each patient with recurrent glioblastoma, a serious brain cancer. Researchers used genetic testing on tumor tissue to pick drugs that target specific mutations. The study…
Matched conditions: RECURRENT GLIOSARCOMA
Phase: PHASE1 • Sponsor: Jennifer Clarke • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New cocktail aims to shrink deadly brain tumors
Disease control CompletedThis phase 2 trial tested a combination of two drugs (retifanlimab and epacadostat) plus radiation and bevacizumab in 51 patients with recurrent glioblastoma, an aggressive brain cancer. The goal was to boost the immune system's attack on the tumor and improve survival. The study…
Matched conditions: RECURRENT GLIOSARCOMA
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC